Brief: Perspective Therapeutics Q3 revenue USD 2.19 million
14/11/2023 21:25
Nov 14 (Reuters) - Perspective Therapeutics Q3 net income USD -10.4 million. * Q3 revenue USD 2.19 million
Recent news on Perspective Therapeutics
See all newsPerspective Therapeutics Q2 net loss widens on higher R&D costs
Brief: Perspective Therapeutics Q2 EPS USD -0.22
Brief: Perspective Therapeutics Expands Therapeutic Focus Areas First Patient Dosed With Vmt-Α-Net In The Meningioma Cohort Of A Phase 1/2A Study
Brief: Perspective Therapeutics Q1 EPS USD -0.25
Perspective Therapeutics rises as experimental cancer drug shows promise